Produktsname: | 2-[[1-[2-[[2-[[2-[[2-[[5-(diaminomethylideneamino)-2-[[2-(methylamino) acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4- hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5- yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid |
CAS Registry Number: | 34273-10-4 |
Synonyme: |
Saralasinum [INN-Latin]; Saralasin [INN:BAN]; Saralasina [INN-Spanish];2-[[1-[2-[[2-[[2-[[2-[[5-(diaminomethylideneamino)-2-[[2-(methylamino) acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4- hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5- yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid; Saralasine [INN-French]; Sar-Arg-Val-Tyr-Val-His-Pro-Ala; |
Molecular Structure: | |
Molecular Formula: | C42H65N13O10 |
Molecular Weight: | 912.0466 |
Dichte: | 1.42 g/cm3 |
Boiling Point: | °Cat760mmHg |
Brechungsindex: | 1.653 |